1. Which of the following is a clinical feature of testosterone deficiency?
A. Insulin sensitivity
B. Hypotension
C. Low energy
D. Increased bone mineral density
2. Which of the following statements concerning testosterone replacement is affirmed by the American Urological Association Guidelines?
A. Exogenous testosterone therapy should not be prescribed to men who are currently trying to conceive.
B. Clinicians should discuss the risk of transference with patients using testosterone gels and creams.
C. Testosterone levels should be measured every 6-12 months while on testosterone once an appropriate level is achieved.
D. All of the above
3. Comparing topical testosterone products, such as gels or transdermal patches, which of the following is true concerning intramuscular testosterone administration?
A. Injectable testosterone products are able to achieve therapeutic levels more often than topical agents.
B. Injectable products produce less fluctuations in testosterone levels than do topical preparations.
C. Injectable products are less cost-effective than topical formulations.
D. None of the above
4. Which of the following counseling points should be conveyed to patients using topical preparations of testosterone?
A. Patients should wash their hands after applying.
B. Patients should cover the area with clothing after drying the area.
C. Patients should wash the area prior to anticipated skin-to-skin contact.
D. All of the above
5. Adverse reactions of testosterone replacement include which of the following?
A. Anemia
B. Worsening sleep apnea
C. Increased sperm count
D. Diuresis
6. Upon initiating testosterone replacement therapy, the dosage should be titrated to clinical symptom control, and to what testosterone level?
A. 50-150 ng/dL
B. 200-350 ng/dL
C. 450-600 ng/dL
D. 1500-3000 ng/dL
Evaluation Questions
7. To what extent did the program meet objective #1?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
8. To what extent did the program meet objective #2?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
9. To what extent did the program meet objective #3?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
10. To what extent did the program meet objective #4?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
11. Rate the effectiveness of how well the program related to your educational needs:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
12. Rate how well the active learning strategies (questions, cases, discussions) were appropriate and effective learning tools:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
13. Rate the quality of the faculty:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
14. Rate the effectiveness and the overall usefulness of the material presented:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
15. Rate the appropriateness of the examination for this activity:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
16. Rate the effectiveness of how well the activity related to your practice needs:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
17. Rate the effectiveness of how well the activity will help you improve patient care:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
18. Will the information presented cause you to change your practice?
A. Yes
B. No
19. Are you committed to making these changes?
A. Yes
B. No
20. As a result of this activity, did you learn something new?
A. Yes
B. No
21. What is your practice setting or area of practice?
A. Community Pharmacy/Independent
B. Community Pharmacy/Chain
C. Hospital/Health Systems
D. Administrative/Pharmacy Director
E. Critical Care Pharmacy
F. Long-term Care
G. Managed Care/PBM
H. Oncology
I. Specialty Pharmacy
J. Industry/Manufacturing
22. How many years have you been in practice?
A. <5
B. 5 – 10
C. 11 – 20
D. >20